Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices’ REBEL At-line Analyzer

A pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company, has adopted REBEL at-line media analyzers in their process development to inform and optimize cell culture feed strategies and media design.…

Read MoreResilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices’ REBEL At-line Analyzer

Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 21 podium presentations and four poster presentations related to the company’s…

Read MoreBausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting

Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development

Vektor Medical, developer of the vMap® next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr.…

Read MoreVektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development

LA FONDATION STALLERGENES GREER SOUTIENT L’INNOVATION ET LA MÉDECINE DE PRÉCISION DANS LE DOMAINE DES ALLERGIES

Stallergenes Greer, laboratoire biopharmaceutique spécialisé dans la recherche, le diagnostic et le traitement des allergies respiratoires, a le plaisir d’annoncer les orientations stratégiques de sa fondation. La Fondation Stallergenes Greer, sous l’égide de la Fondation de France, œuvre à construire…

Read MoreLA FONDATION STALLERGENES GREER SOUTIENT L’INNOVATION ET LA MÉDECINE DE PRÉCISION DANS LE DOMAINE DES ALLERGIES

Stallergenes Greer Foundation to Foster Innovation and Precision Medicine in the Field of Allergy

Stallergenes Greer, a biopharmaceutical company specialising in the research, diagnosis and treatment of respiratory allergies, is pleased to announce its strategic direction for the Stallergenes Greer Foundation. The Stallergenes Greer Foundation, under the aegis of the Fondation de France, aims…

Read MoreStallergenes Greer Foundation to Foster Innovation and Precision Medicine in the Field of Allergy

Mawi DNA Technologies erhält 510(k)-Zulassung für “iSWAB-Respiratory Tract Sample Collection Media-Extraction Less” für SARS-CoV-2

Mawi DNA Technologies (Mawi DNA), ein Biotechnologieunternehmen, das sich auf die Entwicklung und das Design innovativer Technologien für die Bioprobenentnahme konzentriert, gibt bekannt, dass die U.S. Food and Drug Administration (FDA) die 510(k)-Zulassung für die “iSWAB-Respiratory Tract Sample Collection Media-Extraction Less™”…

Read MoreMawi DNA Technologies erhält 510(k)-Zulassung für “iSWAB-Respiratory Tract Sample Collection Media-Extraction Less” für SARS-CoV-2

RRD Simplifies the Production and Distribution of Medical Device Recall Notices

R.R. Donnelley & Sons Company (RRD), a leading global provider of marketing, packaging, print, and supply chain solutions, today announced a new solution designed to streamline the product recall communication process for medical device companies. Seamlessly integrating RRD’s highly refined…

Read MoreRRD Simplifies the Production and Distribution of Medical Device Recall Notices

Exo Works™ Achieves HITRUST and SOC 2 Type II Certifications, Meeting Highest Bar for Patient Data Security

A pioneering medical imaging software and devices company, today announced that Exo Works™, the company’s point-of-care ultrasound workflow solution, has earned Certified status for information security by HITRUST and has successfully completed the Service Organization Control (SOC 2) Type II certification. These achievements provide additional…

Read MoreExo Works™ Achieves HITRUST and SOC 2 Type II Certifications, Meeting Highest Bar for Patient Data Security

EnChroma and UNC’s Department of Health Sciences Team to Help Color Blind Students Address Challenges to Learning on Campus

EnChroma – creators of glasses for color blindness – and the University of North Carolina at Chapel Hill’s Department of Health Sciencestoday announced that special EnChroma glasses for color blindness will be available for students, faculty and staff who are Color Vision Deficient…

Read MoreEnChroma and UNC’s Department of Health Sciences Team to Help Color Blind Students Address Challenges to Learning on Campus

Veristat félicite HIPRA pour l’approbation par l’EMA de son vaccin BIMERVAX®contre COVID-19

Veristat, une organisation mondiale de recherche clinique (CRO) à l’esprit scientifique, a félicité aujourd’hui HIPRA pour l’autorisation de mise sur le marché par l’Agence européenne des médicaments (EMA) et la Commission européenne de BIMERVAX®, un vaccin bivalent avec adjuvant basé sur les…

Read MoreVeristat félicite HIPRA pour l’approbation par l’EMA de son vaccin BIMERVAX®contre COVID-19

Orthofix Expands Solutions for Minimally Invasive Spine Procedures with the Full Commercial Launch of Two Access Retractor Systems

a leading global spine and orthopedics company, today announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures. The Lattus™ Lateral Access System and the Fathom™ Pedicle-Based Retractor System expand the Company’s offering of access…

Read MoreOrthofix Expands Solutions for Minimally Invasive Spine Procedures with the Full Commercial Launch of Two Access Retractor Systems